Q-linea AB (fra:3F8) Share Price

Company Profile

Business description
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
Contact
Dag Hammarskjolds vag 52 A
UppsalaSE-752 37
SWE
T: +46 184443610
https://www.qlinea.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
94

Recommended

These undervalued stocks of high-quality companies could be attractive investments today.

Margaret Giles | 17 March 2025

Ben Graham was the king of flipping deep value stocks. The best investment of his life came from something very different.

Joseph Taylor | 17 March 2025

These shares have surged in price in the last year but are significantly overvalued according to our analysts.

Morningstar | 16 March 2025

Index	Last price	Change	% Change
All Ordinaries	8,082.10	68.80	0.86%
CAC 40	8,073.98	45.70	0.57%
DAX 40	23,154.57	167.75	0.73%
Dow JONES (US)	41,841.63	353.44	0.85%
FTSE 100	8,680.29	47.96	0.56%
HKSE	24,145.57	185.59	0.77%
NASDAQ	17,808.66	54.58	0.31%
Nikkei 225	37,396.52	343.42	0.93%
NZX 50 Index	12,154.23	11.91	-0.10%
S&P 500	5,675.12	36.18	0.64%
S&P/ASX 200	7,854.10	64.40	0.83%
SSE Composite Index	3,426.13	6.57	0.19%